However, a study presented that hydroxychloroquine (HCQ), methotrexate (MTX) and tumor-necrosis factor inhibitors (TNFi) were related to decreased risk of incident diabetes mellitus in RA patients, and glucocorticoid (GC) was associated with increased risk of diabetes mellitus in a dose-dependent manner (44). Here, TNF is linked to diabetes mellitus.